Norzer Biology Group

PharmaceuticalsAngelBeijing, China

Latest round

Angel

Last raised

Mar 2017

Total raised

Undisclosed

Investors

1

About Norzer Biology Group

Established in 2013 and based in Beijing, China, Norzer Biology Group is a medical company that focuses on the research and development of natural products and pharmaceutical products. The company’s main business is the research, development, and production of natural products and pharmaceuticals derived from plant extracts. The company’s self-developed products include Allicin, Glycyrrhizic Acid, and Triptolide, among others. The company generates revenue by providing contract research and manufacturing services, as well as through the direct sale of its proprietary products to pharmaceutical companies, health supplement manufacturers, and cosmetic industries.

Who invested in Norzer Biology Group

1 investor across 1 round

See all investors in Norzer Biology Group

Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.

Funding rounds

  1. Angel

    Mar 14, 2017

    Amount

    Undisclosed

    Investors

    Locked

Questions about Norzer Biology Group

Who invested in Norzer Biology Group?

Norzer Biology Group has 1 investor on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.

How much funding has Norzer Biology Group raised?

Norzer Biology Group has raised 1 venture round. Sign up free to see how much each round raised and the total.

When did Norzer Biology Group last raise money?

Norzer Biology Group's most recent round on record is a Angel, in Mar 2017.

What does Norzer Biology Group do?

Established in 2013 and based in Beijing, China, Norzer Biology Group is a medical company that focuses on the research and development of natural products and pharmaceutical products.

Where is Norzer Biology Group headquartered?

Norzer Biology Group is headquartered in Beijing, China.

Which VCs invest in companies like Norzer Biology Group?

Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Peak XV Partners, MPCi and Luminous Ventures back pharmaceuticals companies at Norzer Biology Group's stage. Their profiles are linked below.

Raising like Norzer Biology Group? Find the right VCs.

Capital Atlas matches your startup to active investors by stage, sector and region.

Free to start. Upgrade when you're ready to reach out.